Literature DB >> 25266455

Spondyloarthritis: Closing the gap in psoriatic arthritis.

Christopher Ritchlin1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25266455     DOI： 10.1038/nrrheum.2014.169

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Early psoriatic arthritis.

Authors:  David Kane; Sanjay Pathare
Journal:  Rheum Dis Clin North Am       Date:  2005-11       Impact factor: 2.670

Review 2.  Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.

Authors:  Arthur F Kavanaugh; Christopher T Ritchlin
Journal:  J Rheumatol       Date:  2006-05-15       Impact factor: 4.666

3.  Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.

Authors:  Ning Wu; Yuan-Chi Daisy Lee; Neel Shah; David J Harrison
Journal:  Clin Ther       Date:  2014-07-23       Impact factor: 3.393

4.  Differences in the patient's and the physician's perspective of disease in psoriatic arthritis.

Authors:  Stefan W H Dandorfer; Jürgen Rech; Bernhard Manger; Georg Schett; Matthias Englbrecht
Journal:  Semin Arthritis Rheum       Date:  2012-03-16       Impact factor: 5.532

5.  Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.

Authors:  Karen Minde Fagerli; Elisabeth Lie; Désirée van der Heijde; Marte Schrumpf Heiberg; Synøve Kalstad; Erik Rødevand; Knut Mikkelsen; Ase Stavland Lexberg; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2013-04-05       Impact factor: 19.103

6.  Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.

Authors:  Janice A Husted; Arane Thavaneswaran; Vinod Chandran; Lihi Eder; Cheryl F Rosen; Richard J Cook; Dafna D Gladman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

7.  Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives.

Authors:  M Englbrecht; Y Wang; M Ronneberger; B Manger; N Vastesaeger; D J Veale; G Schett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07       Impact factor: 4.794

8.  Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease.

Authors:  Laura C Coates; Oliver FitzGerald; Dafna D Gladman; Neil McHugh; Philip Mease; Vibeke Strand; Philip S Helliwell
Journal:  Arthritis Rheum       Date:  2013-06

Review 9.  Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Authors:  Philip Helliwell; Laura Coates; Vinod Chandran; Dafna Gladman; Maarten de Wit; Oliver FitzGerald; Arthur Kavanaugh; Vibeke Strand; Philip J Mease; Wolf-Henning Boehncke; Richard G Langley; Ennio Lubrano; Mara Maccarone; Hendrik Schulze-Koops; Corinne Miceli-Richard; Ruben Queiro
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

10.  Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Authors:  Matteo Nicola Dario Di Minno; Rosario Peluso; Salvatore Iervolino; Anna Russolillo; Roberta Lupoli; Raffaele Scarpa
Journal:  Ann Rheum Dis       Date:  2013-06-14       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.